EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Obinutuzumab is Effective as an Initial Treatment for PLA2R-Associated Primary Membranous Nephropathy: A Retrospective, Single-Center Trial

Xue-Qi Li, Yang Liu, Ze-Yu Cai, Tie-Gang Lv, Jian Hao

Drug Design, Development and Therapy · 2025-07 · Volume 19 · 5961-5972

DOI: 10.2147/dddt.s527661 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2025-07. Verfasst von Xue-Qi Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Nephrology, The Affiliated Hospital of Inner Mongolia Medical University, Hohhot, Inner Mongolia Autonomous Regio…. Hauptthemen laut MEDLINE: Glomerulonephritis, Membranous, Receptors, Phospholipase A2, Antibodies, Monoclonal, Humanized. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glomerulonephritis, MembranousReceptors, Phospholipase A2Antibodies, Monoclonal, HumanizedHumansMaleFemaleMiddle AgedRetrospective StudiesAdultAgedRituximabAutoantibodies

Stichwörter der Autor:innen

PLA2Rmembranous nephropathyobinutuzumabproteinuria

Substanzen

Receptors, Phospholipase A2Antibodies, Monoclonal, HumanizedobinutuzumabRituximabPLA2R1 protein, humanAutoantibodies

Autor:innen und Institutionen

  • Department of Medicine, Division of Nephrology, The Affiliated Hospital of Inner Mongolia Medical University, Hohhot, Inner Mongolia Autonomous Region, 010050, China.
  • Department of Medicine, Division of Radiology, The Affiliated Hospital of Inner Mongolia Medical University, Hohhot, Inner Mongolia Autonomous Region, 010050, People's Republic of China.

Zitieren

APA

Li, X. Q., Liu, Y., Cai, Z. Y., Lv, T. G., & Hao, J. (2025). Obinutuzumab is Effective as an Initial Treatment for PLA2R-Associated Primary Membranous Nephropathy: A Retrospective, Single-Center Trial. Drug Design, Development and Therapy, Volume 19, 5961-5972. https://doi.org/10.2147/dddt.s527661

Vancouver

Li XQ, Liu Y, Cai ZY, Lv TG, Hao J. Obinutuzumab is Effective as an Initial Treatment for PLA2R-Associated Primary Membranous Nephropathy: A Retrospective, Single-Center Trial. Drug Design, Development and Therapy. 2025;Volume 19:5961-5972. doi:10.2147/dddt.s527661

BibTeX
@article{Li2025,
  author = {Li, Xue-Qi and Liu, Yang and Cai, Ze-Yu and Lv, Tie-Gang and Hao, Jian},
  title = {Obinutuzumab is Effective as an Initial Treatment for PLA2R-Associated Primary Membranous Nephropathy: A Retrospective, Single-Center Trial},
  journal = {Drug Design, Development and Therapy},
  year = {2025},
  volume = {Volume 19},
  pages = {5961--5972},
  doi = {10.2147/dddt.s527661}
}
Kostenlos starten →